Myosin Light Chain Kinase Inhibitors Can Block Invasion and Adhesion of Human Pancreatic Cancer Cell Lines
Authors:
- Kenzo KanekoKKKenzo Kaneko
- Kennichi SatohKSKennichi Satoh
- Atsushi MasamuneAMAtsushi Masamune
- Akihiko SatohASAkihiko Satoh
- Tooru ShimosegawaTSTooru Shimosegawa
- 1 January 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Pancreas
- Vol. 24 (1) , 34-41
Abstract
Invasion and metastasis of pancreatic cancer (PC) require cell motility and adhesion, which depend on the activity of cytoskeleton. A cytoskeletal component indispensable for these processes is myosin II, the cytoplasmic analogue of smooth and skeletal muscle myosin. Because the activity of myosin II is accelerated by phosphorylation of myosin II on its regulatory light chain (RLC) by myosin light chain kinase (MLCK), we used two specific MLCK inhibitors, ML-7 and ML-9, for suppression of motility and adhesion of PC cell lines. Both drugs were potent inhibitors, as measured by in vitro motility assay and adhesion assay. When treated with the same concentration of ML-7, the PC cells were rounded up, and the number of stress fibers was reduced markedly. The in vitro migration and adhesion of PC cells were inhibited by ML-7 and ML-9 in a dose-dependent manner, supporting a specific and competitive inhibition of MLCK by these drugs. The inhibition occurred at nontoxic concentrations. These results highlight the importance of myosin II in the invasion and metastasis of PC cells and suggest the possibility that blocking of myosin II activity by a specific MLCK inhibitor may be a therapeutic strategy for preventing the invasion and metastasis of PC.Keywords
This publication has 30 references indexed in Scilit:
- Integrin ?6?1 role in metastatic behavior of human pancreatic carcinoma cellsInternational Journal of Cancer, 1999
- Expression of Transforming Growth Factor β1 (TGFβ1) and Its Receptors in Pancreatic Duct Cell Carcinoma and in Chronic PancreatitisPancreas, 1998
- Cholecystokinin receptor antagonist, loxiglumide, inhibits invasiveness of human pancreatic cancer cell linesFEBS Letters, 1996
- Expression and Function of Receptors for Extracellular Matrix Proteins in Human Ductal Adenocarcinomas of the PancreasPancreas, 1996
- Genetic Approaches to Molecular MotorsAnnual Review of Cell Biology, 1992
- Biology of tumour metastasisThe Lancet, 1992
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- Regulation of cytoplasmic and smooth muscle myosinCurrent Opinion in Cell Biology, 1991
- Active site trapping of nucleotide by smooth and non-muscle myosinsJournal of Molecular Biology, 1988
- Calcium control of actin-myosin based contraction in triton models of mouse 3T3 fibroblasts is mediated by the myosin light chain kinase (MLCK)-calmodulin complexExperimental Cell Research, 1983